New AI approach enhances cardiovascular risk assessment

Risk calculators are used to evaluate disease risk for millions of patients, making their accuracy crucial.

Spexis Announces Changes to the Executive Committee – Biotech Investments

Spexis AG / Key word(s): Personnel/Personnel 01-Nov-2023 / 07:20 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely

November 2, 2023

Spexis granted definitive moratorium status until 25 November 2024, subject to monthly progress report obligations, and which can be potentially extended at the request of the administrators. – Biotech Investments

Spexis AG / Key word(s): Miscellaneous 29-Jul-2024 / 07:15 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely

July 30, 2024

Who Really Needs a Yearly COVID Booster?

In this video interview, Paul Offit, MD, of Children’s Hospital of Philadelphia, discusses the rationale behind the CDC recommendation for a yearly COVID booster, and

September 28, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.